journal article·2019-07

The effect of nacre extract on cord blood‐derived endothelial progenitor cells: A natural stimulus to promote angiogenesis?

Anne‐Sophie Willemin, Ganggang Zhang, Emilie Velot, Arnaud Bianchi, Veronique Decot, Marthe Rousseau, Pierre Gillet, Vanessa Moby

Publisher page

Abstract

Abstract Angiogenesis is a critical parameter to consider for the development of tissue‐engineered bone substitutes. The challenge is to promote sufficient vascularization in the bone substitute to prevent cell death and to allow its efficient integration. The capacity of nacre extract to restore the osteogenic activity of osteoarthritis osteoblasts has already been demonstrated. However, their angiogenic potential on endothelial progenitor cells (EPCs) was not yet explored. Therefore, the current study aimed at investigating if nacreous molecules affect EPC behavior. The gene and protein expression levels of endothelial cell (EC)‐specific markers were determined in EPCs cultivated in presence of a nacre extract (ethanol soluble matrix [ESM] at two concentrations: 100 μg/mL and 200 μg/mL (respectively abbreviated ESM100 and ESM200)). Cell functionality was explored by proangiogenic factors production and in vitro tube formation assay. ESM200 increased the expression of some EC‐specific genes. The in vitro tube formation assay demonstrated that ESM200 stimulated tubulogenesis affecting angiogenic parameters. We demonstrated that a stimulation with 200 μg/mL of ESM increased angiogenesis key elements. This in vitro study strongly highlights the proangiogenic effect of ESM. Due to its osteogenic properties, previously demonstrated, ESM could constitute the key element to develop an ideal prevascularized bone substitute. © 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2019.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Hemostasis and retained surgical items

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), UMR 7365 CNRS‐Université de Lorraine Vandœuvre‐Lès‐Nancy, F‐54505 France

Department of Orthopedics The First Affiliated Hospital of Zhengzhou University Zhengzhou China

Faculté de Pharmacie Vandœuvre‐lès‐Nancy, F‐54505 France

CHRU de Nancy Unité de Thérapie Cellulaire et Tissus Vandœuvre‐lès‐Nancy, F‐54505 France

Université de Lyon, UJM‐Saint Etienne, INSERM, SAINBIOSE U1089 Saint‐Etienne, F‐42000 France

CHRU de Nancy‐Brabois, Service Odontologie Vandœuvre‐lès‐Nancy, F‐54500 France

Faculté d'Odontologie Université de Lorraine Vandœuvre‐lès‐Nancy, F‐54505 France

Funding

French Ministry of Higher Education and Research

References (50)

Show source-provided references
1. 10.1016/S1359-6446(03)02866-610.1016/S1359-6446(03)02866-6 ↗
2. 10.1196/annals.1365.03510.1196/annals.1365.035 ↗
3. 10.1016/j.clinbiochem.2012.03.02110.1016/j.clinbiochem.2012.03.021 ↗
4. 10.1007/s00441-011-1184-810.1007/s00441-011-1184-8 ↗
5. Clinical results of autologous bone augmentation harvested from the mandibular ramus prior to implant placement. An analysis of 104 cases
6. 10.5312/wjo.v6.i10.75410.5312/wjo.v6.i10.754 ↗
7. 10.1615/CritRevBiomedEng.v40.i5.1010.1615/CritRevBiomedEng.v40.i5.10 ↗
8. 10.3389/fbioe.2017.0001710.3389/fbioe.2017.00017 ↗
9. 10.4161/org.2330610.4161/org.23306 ↗
10. 10.1016/j.tibtech.2009.07.00110.1016/j.tibtech.2009.07.001 ↗
11. 10.3389/fendo.2013.0010610.3389/fendo.2013.00106 ↗
12. 10.1038/bonekey.2015.2910.1038/bonekey.2015.29 ↗
13. 10.1007/s00223-012-9689-z10.1007/s00223-012-9689-z ↗
14. 10.22203/eCM.v027a0110.22203/eCM.v027a01 ↗
15. 10.1007/s00005-014-0285-y10.1007/s00005-014-0285-y ↗
16. 10.4155/tde.12.5010.4155/tde.12.50 ↗
17. 10.1159/00034510810.1159/000345108 ↗
18. 10.2741/s32110.2741/s321 ↗
19. 10.1016/j.actbio.2017.03.00310.1016/j.actbio.2017.03.003 ↗
20. The water‐soluble matrix fraction from the nacre of Pinctada maxima produces earlier mineralization of MC3T3‐E1 mouse pre‐osteoblasts
21. 10.1002/jbm.a.3155310.1002/jbm.a.31553 ↗
22. 10.14348/molcells.2015.231510.14348/molcells.2015.2315 ↗
23. 10.1002/jbm.a.3593910.1002/jbm.a.35939 ↗
24. 10.1016/S8756-3282(99)00141-610.1016/S8756-3282(99)00141-6 ↗
25. 10.1016/S0142-9612(00)00213-110.1016/S0142-9612(00)00213-1 ↗
26. 10.1359/jbmr.2001.16.12.223210.1359/jbmr.2001.16.12.2232 ↗
27. 10.1016/S0764-4469(97)86933-810.1016/S0764-4469(97)86933-8 ↗
28. 10.1016/j.biomaterials.2012.06.09810.1016/j.biomaterials.2012.06.098 ↗
29. 10.2298/SARH0910518V10.2298/SARH0910518V ↗
30. 10.1016/j.jsb.2015.10.01210.1016/j.jsb.2015.10.012 ↗
31. 10.1016/j.jsb.2016.03.01610.1016/j.jsb.2016.03.016 ↗
32. 10.1038/nmeth.208910.1038/nmeth.2089 ↗
33. 10.1016/j.biomaterials.2014.02.01210.1016/j.biomaterials.2014.02.012 ↗
34. 10.1089/ten.2006.12.268510.1089/ten.2006.12.2685 ↗
35. 10.1016/j.biomaterials.2010.08.03610.1016/j.biomaterials.2010.08.036 ↗
36. 10.1111/j.1365-2184.2010.00722.x10.1111/j.1365-2184.2010.00722.x ↗
37. 10.4049/jimmunol.179.11.748810.4049/jimmunol.179.11.7488 ↗
38. 10.1016/0267-6605(90)90022-N10.1016/0267-6605(90)90022-N ↗
39. 10.1016/0040-8166(92)90037-810.1016/0040-8166(92)90037-8 ↗
40. 10.1007/BF0031688110.1007/BF00316881 ↗
41. 10.1007/s11033-011-1088-410.1007/s11033-011-1088-4 ↗
42. 10.1161/ATVBAHA.107.15145610.1161/ATVBAHA.107.151456 ↗
43. 10.1093/glycob/cwu09410.1093/glycob/cwu094 ↗
44. 10.1006/exmp.2002.242410.1006/exmp.2002.2424 ↗
45. 10.15252/msb.2016714410.15252/msb.20167144 ↗
46. 10.1038/nrm317610.1038/nrm3176 ↗
47. 10.3109/13880209.2012.72113010.3109/13880209.2012.721130 ↗
48. 10.1002/jbm.a.3462910.1002/jbm.a.34629 ↗
49. Repair of critical size bone defects with porous poly(D,L‐lactide)/nacre nanocomposite hollow scaffold
50. 10.1371/journal.pone.014371310.1371/journal.pone.0143713 ↗